Exp Clin Endocrinol Diabetes 2004; 112(9): 514-519
DOI: 10.1055/s-2004-821314
Article

J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

In vivo Properties of the Urinary Bladder Wall and their Modulation by Estradiol and Raloxifene in a Rat Model

A. Schultens1 , T. Becker1 , D. Balmer1 , D. Seidlová-Wuttke1 , W. Wuttke1
  • 1Department of Clinical and Experimental Endocrinology, University of Goettingen, Germany
Further Information

Publication History

Publication Date:
25 October 2004 (online)

Abstract

Objectives: Urinary incontinence is a common symptom of urogenital aging that affects a considerable proportion of postmenopausal women. Morphological and morphometrical modulation of the bladder by estrogen are known. Yet data showing that this translates into changes of in vivo function of the urinary bladder are missing.

Methods: We measured urodynamic parameters in anaesthetized, surviving rats. Following ovariectomy animals were divided into three groups and fed either an estradiol-, raloxifene-, or unsupplemented soy-free formula for ten weeks. Via a transurethral catheter the intravesical pressure was recorded during a stretch period (the urinary bladder was filled), and a one-minute isometric accommodation period immediately after the filling period. Upon termination of the experiment upper and lower halves of the bladder were processed histologically.

Results: The estrogen-, and raloxifene-treated animals showed significantly higher pressures in responses to rapid stretch. Bladder compliance during the isometric period on the other hand was not significantly affected by these treatments. Thickness of the epithelial layer, collagen content and muscle bundles were significantly increased by estrogen and raloxifene treatment.

Conclusions: This is a good animal model to investigate modulation of detrusor muscle contractility and stiffness. Both estradiol and raloxifene increase bladder contractility. Urinary bladder morphology indicates that estrogen acts primarily in the upper half of this organ since significant effects on collagen content and muscle fibers are only found in this part.

References

  • 1 Blaivas J G, Berger Y. Surgical treatment for male geriatric incontinence.  Clin Geriatr Med. 1986;  2 777-787
  • 2 Burgio K L, Matthews K A, Engel B T. Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women.  J Urol. 1991;  146 1255-1259
  • 3 Chaikin D C, Blaivas J G. Voiding dysfunction: definitions.  Curr Opin Urol. 2001;  11 395-398
  • 4 Chun A L, Wein A J, Harkaway R, Levin R M. Comparison of urinary bladder function in sexually mature and immature male and female rats.  T J Urol. 1990;  143 1267-1271
  • 5 Dering M A, Santer R M, Watson A H. Age-related changes in the morphology of preganglionic neurons projecting to the rat hypogastric ganglion.  J Neurocytol. 1996;  25 555-563
  • 6 Diep N, Constantinou C E. Age dependent response to exogenous estrogen on micturition, contractility and cholinergic receptors of the rat bladder.  Life Sci. 1999;  64 279-289
  • 7 Gollapudi L, Oblinger M M. Estrogen effects on neurite outgrowth and cytoskeletal gene expression in ERalpha-transfected PC12 cell lines.  Exp Neurol. 2001;  171 308-316
  • 8 Grady D, Brown J S, Vittinghoff E, Applegate W, Varner E, Snyder T. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study.  Obstet Gynecol. 2001;  97 116-120
  • 9 Jackson S, Shepherd A, Brookes S, Abrams P. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial.  Br J Obstet Gynecol. 1999;  106 711-718
  • 10 Levin R M, Jacobowitz D, Wein A J. Autonomic innervation of rabbit urinary bladder following estrogen administration.  Urology. 1981;  17 449-453
  • 11 Linford N, Wade C, Dorsa D. The rapid effects of estrogen are implicated in estrogen-mediated neuroprotection.  J Neurocytol. 2000;  29 367-374
  • 12 Lovatsis D, Drutz H P. The role of estrogen in female urinary incontinence and urogenital aging: a review.  Ostomy/wound management. 1998;  44 48-53
  • 13 Luna M T, Hirakawa T, Nakano H. Urinary incontinence in women seen in the obstetrics and gynecology clinic.  Int Urogynecol J Pelvic Floor Dysfunct. 2000;  11 277-281
  • 14 Madeiro A, Girao M, Sartori M, Acquaroli R, Baracat E, Rodrigue de Lima G. Effects of the association of androgen/estrogen on the bladder and urethra of castrated rats.  Clin Exp Obstet Gynecol. 2002;  29 117-120
  • 15 Mäkelä S, Strauss L, Kuiper G, Valve E, Salmi S, Santti R, Gustafsson J A. Differential expression of estrogen receptors a and β in adult rat accessory sex glands and lower urinary tract.  Mol Cell Endocrinol. 2000;  170 219-229
  • 16 Milsom I, Abrams P, Cardozo L, Roberts R G, Thuroff J, Wein A J. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study.  BJU Int. 2001;  87 760-766
  • 17 Moller L A, Lose G, Jorgensen T. Incidence and remission rates of lower urinary tract symptoms at one year in women aged 40 - 60: longitudinal study.  BMJ. 2000;  320 1429-1432
  • 18 Nachtigall L. Towards better recognition of urogenital aging. Proceedings of the 8th International Congress on the Menopause.  Am J Obstet Gynecol. 1998;  178 243-244
  • 19 Patisaul H B, Dindo M, Whitten P L, Young L J. Soy isoflavone supplements antagonize reproductive behaviour and estrogen receptor alpha- and beta-dependent gene expression in the brain.  Endocrinology. 2001;  142 2946-2952
  • 20 Resnick N M, Yalla S V. Geriatric incontinence and voiding dysfunction. PC Wellsh Campbell's Urology. 7th ed. WB Saunders 1998: 1044-1058
  • 21 Samsioe G. Urogenital aging - a hidden problem.  Am J Obstet Gynecol. 1998;  178 245-249
  • 22 Sanchez-Ortiz R F, Wang Z, Menon C, DiSanto M E, Wein A J, Chacko S. Estrogen modulates the expression of myosin heavy chain in detrusor smooth muscle.  Am J Physiol Cell Physiol. 2001;  280 C433-C440
  • 23 Sartori M G, Girao M J, de Jesus S M, Sartori J P, Baracat E C, Rodrigues de Lima G. Quantitative evaluation of collagen and muscle fibers in the lower urinary tract of castrated and under-hormone replacement female rats.  Clin Exp Obstet Gynecol. 2001;  28 92-96
  • 24 Sherburn M, Guthrie J R, Dudley E C, O'Connell H E, Dennerstein L. Is incontinence associated with menopause?.  Obstet Gynecol. 2001;  98 628-633
  • 25 Stenberg A, Heimer G, Ulmsten U, Cnattingius S. Prevalence of genitourinary and other climacteric symptoms in 61-year-old women.  Maturitas. 1996;  24 31-36
  • 26 Watanabe T, Constantinou C E. Analysis of pressure/flow characteristics in the female rat and their pharmacologic modulation.  Neurourol Urodyn. 1996;  15 513-527
  • 27 Zhu Q, Ritchie J, Marouf N, Dion S B, Resnick N M, Elbadawi A, Kuchel G A. Role of ovarian hormones in the pathogenesis of impaired detrusor contractility: evidence in ovariectomized rodents.  J Urol. 2001;  166 1136-1141

Prof. Dr. W. Wuttke

Department of Clin. and Exp. Endocrinology
University of Goettingen

Robert-Koch-Straße 40

37075 Goettingen

Germany

Phone: + 49551396714

Fax: + 49 5 51 39 65 18

Email: ufkendo@med.uni-goettingen.de